secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2023-10-10T23:59:59+00:00
Accession:  0000950170-23-052653
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals Amends Bylaws to Add Universal Proxy Rule Compliance Requirements for Director Nominations
--------------------------------------------------------------------------------

- Board approved amended and restated bylaws on October 4, 2023.
- Amended bylaws revise procedures and disclosure for director nominations.
- Stockholders must provide evidence of compliance with Rule 14a-19 no later than five business days before the meeting.
- Changes are effective as of October 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023052653/0000950170-23-052653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023052653/tern-20231004.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-052653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer